FOX BIZ NEWS: FDA panel reviews 1st new Alzheimer’s drug in 2 decades


FDA panel reviews 1st new Alzheimer’s drug in 2 decades



A panel of outside experts meets Friday to advise the Food and Drug Administration on aducanumab, a drug from Cambridge, Massachusetts-based Biogen Inc. and Japan’s Eisai Co. FDA doesn’t always follow the panel’s advice but usually does and has until March to decide.

Comments

Post a Comment

Popular posts from this blog

FOX BIZ NEWS: Phantom Space startup announces world's first 100% US-based satellite supply chain after acquiring StratSpace

Image
Phantom Space startup announces world's first 100% US-based satellite supply chain after acquiring StratSpace The race is on to democratize the rocket-launch industry, and Phantom Space Corp., a roughly two-year-old startup, continued its warp-speed flight toward that goal Tuesday, announcing the acquisition of StratSpace, a major U.S. aerospace firm.
Read more